DOI: 10.1128/AAC.02188-18
Article Information
PubMed
Published By
History
- Received October 17, 2018
- Returned for modification November 19, 2018
- Accepted January 4, 2019
- Published online February 26, 2019.
Copyright & Usage
Copyright © 2019 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (January 07, 2019).
- You are viewing the most recent version of this article.
Author Information
- Cai-Yun Zhaoa,
- Yuan Lva,
- Yan Zhua,
- Min-Ji Weia,
- Meng-Ying Liub,
- Xi-Wei Jia,
- Zi-Sheng Kanga,
- Ya-Hong Xiaa,
- Ji-Hong Tiana,
- Yan Maa and
- Yan Liua
- aInstitute of Clinical Pharmacology, Peking University First Hospital, Beijing, China
- bBeijing Sihuan Pharmaceuticals Co., Ltd., Beijing, China
- Address correspondence to Yuan Lv, lyzx5857{at}163.com.
Citation Zhao C-Y, Lv Y, Zhu Y, Wei M-J, Liu M-Y, Ji X-W, Kang Z-S, Xia Y-H, Tian J-H, Ma Y, Liu Y. 2019. A first-in-human safety, tolerability, and pharmacokinetics study of benapenem in healthy Chinese volunteers. Antimicrob Agents Chemother 63:e02188-18. https://doi.org/10.1128/AAC.02188-18.
